News

GEN - Genetic Engineering and Biotechnology News4h
Old Vaccine, New Tricks: PIE-seq Reveals How BCG Reprograms Immunity
A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...
Common energy drink ingredient linked to leukemia cell growth in study
Aggressive blood cancers all originate in the bone marrow, where the research shows cancer cells depend on the ingredient ...
Pharmabiz2d
Sanofi completes acquisition of DR-0201, a bispecific myeloid cell engager from Dren Bio
Sanofi completes acquisition of DR-0201, a bispecific myeloid cell engager from Dren Bio: Paris Wednesday, May 28, 2025, 09:00 Hrs [IST] Sanofi announces the completion of its acq ...
EuropaWire2d
Sanofi Completes $600 Million Acquisition of DR-0201 to Enhance Immunology Pipeline and Advance Autoimmune Disease Treatments
Sanofi has completed the acquisition of DR-0201 from Dren Bio, now renamed SAR448501, to enhance its immunology pipeline. This bispecific myeloid ...
PipelineReview.com3d
Sanofi completes acquisition of DR-0201
PARIS, France I May 27, 2025 I Sanofi announces the completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc., ...
The Manila Times3d
Press Release: Sanofi completes acquisition of DR-0201
Paris, May 27, 2025. Sanofi announces the completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc., a private clinical-stage biopharmaceutical company.